SecurityBB / Blackberry Limited (09228F103)
Latest Market Date2018-08-17
Short Volume351,764
Market Volume 5,109,800
Short Percent 7%

Short Interest and Volume

BB / Blackberry Limited short volume is shown in the following chart. Short Volume is a data set that can be used to understand investor sentiment. When an investor makes a short sale, they do so with the belief that a security will decline in price. If the short sale volume increases as a percentage of the total volume, then that suggests a bearish (negative) sentiment by the market. If short sale volume decreases as a percentage of total volume, then that suggests a bullish (positive) sentiment.

Short Volume
Total number of short shares traded on the major US markets each day
Short Percent
Total number of short shares traded divided by the total shares traded each day
Short Interest
Total number of open short positions of a security, divided by the total float (not shown)
Short Squeeze
When a company with a high degree of short interest increases in price, which forces short sellers to "cover" their short interest buy buying actual shares, which in turn drives the price up even further.

Note that Short Percent on this page is not the same as Short Interest. Short Interest is a measure of the number of open short positions of a security, divided by the total float. Short Percent is the daily short volume divided by the total volume. Short Interest is not available for this security at this time.

Market Date Total Volume Short Volume Short Percent
2018-08-17 5,109,800 351,764 6.88
2018-08-16 4,037,000 315,186 7.81
2018-08-15 7,225,800 468,501 6.48
2018-08-14 3,759,200 357,106 9.50
2018-08-13 5,953,800 573,226 9.63
2018-08-10 7,463,800 636,343 8.53
2018-08-09 7,797,600 681,410 8.74
2018-08-08 10,583,400 937,584 8.86
2018-08-07 13,340,200 902,936 6.77
2018-08-06 4,835,800 309,997 6.41

Related Articles

REPH: Recro Pharma Analysis and Research Report

12h - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

13h - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

13h - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

Silicon Investor Message Boards

This table lists all message boards related to BB / Blackberry Limited on message board site Silicon Investor.

BB: BlackBerry (fka RIMM: Research in Motion) BB: BlackBerry (fka RIMM: Research in Motion) BB: BlackBerry (fka RIMM: Research in Motion) Hot Tubbers Anonymous Hot Tubbers Anonymous Hot Tubbers Anonymous
BMY (bristol myers squibb) BMY (bristol myers squibb) BMY (bristol myers squibb) Undervalued - OTC/BB Stocks Undervalued - OTC/BB Stocks Undervalued - OTC/BB Stocks
Nintendo (BB:NTDOY) Great Time To Jump In! Nintendo (BB:NTDOY) Great Time To Jump In! Nintendo (BB:NTDOY) Great Time To Jump In! NWL: Newell Rubbermaid, Inc. NWL: Newell Rubbermaid, Inc. NWL: Newell Rubbermaid, Inc.
The Epic American Credit and Bond Bubble Laboratory The Epic American Credit and Bond Bubble Laboratory The Epic American Credit and Bond Bubble Laboratory Post Grubbers Trophy Case Post Grubbers Trophy Case Post Grubbers Trophy Case
DIGITCOM (DGIV-OTC-bb)Information Thread DIGITCOM (DGIV-OTC-bb)Information Thread DIGITCOM (DGIV-OTC-bb)Information Thread OTC:BB STOCK PICKING Challenge OTC:BB STOCK PICKING Challenge OTC:BB STOCK PICKING Challenge
CUSIP: 09228F103